Clin Colon Rectal Surg 2002; 15(1): 007-016
DOI: 10.1055/s-2002-23563
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Staging of Rectal Cancer and the Pathologist's Role in Assessing the Quality of Rectal Cancer Surgery

Carolyn C. Compton
  • Department of Pathology, McGill University, Montreal, Quebec, Canada
Further Information

Publication History

Publication Date:
03 April 2002 (online)

ABSTRACT

For rectal cancer, local recurrence following surgical treatment is a grave complication that occurs in as many as 25% of cases. Pathological examination of the surgical resection specimen plays a primary role in assessing both the surgery- and tumor-related factors that contribute to the risk of recurrence. Tumor stage is considered the most accurate indicator of outcome in rectal cancer overall, but additional pathologic features that have been shown to have stage-independent prognostic significance include tumor grade; histologic type; extent of extramural penetration by tumor; neural, venous, and/or lymphatic invasion; tumor border configuration; and host lymphoid response. The most powerful predictor of local recurrence and overall outcome in rectal cancer, however, is the macroscopic quality of the mesorectum in the resection specimen and the proximity of the tumor to the circumferential (radial) resection margin.

REFERENCES

  • 1 Abulafi A M, Williams N S. Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy.  Br J Surg . 1994;  81 7-19
  • 2 Williams N S. Pathological basis for restorative surgery in low rectal cancer.  J R Soc Med . 1989;  82 237-238
  • 3 Williams N S, Dixon M F, Johnston D. Reapppraisal of the five centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival.  Br J Surg . 1983;  70 150-154
  • 4 Cross S S, Bull A D, Smith J HF. Is there any justification for the routine examination of bowel resection margins in colorectal adenocarcinoma?.  J Clin Pathol . 1989;  42 1040-1042
  • 5 Kapiteijn E, Marijnen C AM, Nagtegaal I D. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.  N Engl J Med . 2001;  345 638-646
  • 6 Harnsberger J R, Vernava III M V, Longo W E. Radical abdominopelvic lymphadenectomy: historic perspective and current role in the surgical management of rectal cancer.  Dis Colon Rectum . 1994;  37 73-87
  • 7 Phillips R K, Hittinger R, Blesovsky L. Local recurrence following ``curative'' surgery for large bowel cancer. I: The overall picture.  Br J Surg . 1984;  71 12-16
  • 8 Kapiteijn E, Marijnen C AM, Colenbrander A C. Local recurrence in patients with rectal cancer, diagnosed between 1988 and 1992; a population-based study in the west Netherlands.  Eur J Surg Oncol . 1998;  24 528-535
  • 9 MacFarlane J K, Ryall R D, Heald R J. Mesorectal excision for rectal cancer.  Lancet . 1993;  341 457-460
  • 10 Enker W E, Thaler H T, Cranor M L, Polyak T. Total mesorectal excision in the operative management of carcinoma of the rectum.  J Am Coll Surg . 1995;  181 335-346
  • 11 Aitken R J. Mesorectal excision for rectal cancer.  Br J Surg . 1996;  83 214-216
  • 12 Quirke P. Limitations of existing systems of staging for rectal cancer: the forgotten margin In: Rajagopalan NT, ed. Rectal Cancer Research. New York: Springer-Verlag 2001: 63-81
  • 13 Martling A L, Holm T, Rutqvist L-E. Effect of a surgical training programme on outcome of rectal cancer in the county of Stockholm.  Lancet . 2000;  356 93-96
  • 14 Stacchi L, Nelson H, Sargent D J. Impact of surgical and pathological variables in rectal cancer: a United States community and cooperative group report.  N Engl J Med . 2001;  19 3895-3902
  • 15 Stearns Jr W M, Binkley G E. The influence of location on prognosis in operable rectal cancer.  Surg Gynecol Obstet . 1953;  96 368-372
  • 16 Morson B C, Vaughan E G, Bussey H JR. Pelvic recurrence after excision of rectum for carcinoma.  BMJ . 1963;  ii 13-18
  • 17 Vandertoll D J, Beahrs O H. Carcinoma of the rectum and low sigmoid. Evaluation of anterior resection in 1766 favourable lesions.  Arch Surg . 1965;  90 793-798
  • 18 Moosa A R, Ree P C, Marks J E. Factors influencing local recurrence after abdominoperineal resection for cancer of the rectum and rectosigmoid.  Br J Surg . 1975;  62 727-730
  • 19 Pilipshen S J, Heilweil M, Quan S H. Patterns of pelvic recurrence following definitive resections of rectal cancer.  Cancer . 1954;  53 1354-1362
  • 20 Bentzen S M, Balslev I, Pedersen M. Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with and without adjuvant post-operative radiotherapy. A multivariate regression analysis.  Br J Cancer . 1992;  65 102-107
  • 21 Compton C C. Updated protocol for the examination of specimens removed from patients with colorectal carcinoma.  Arch Pathol Lab Med . 2000;  124 1016-1025
  • 22 Newland R, Dent O, Lyttle M. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients.  Cancer . 1994;  73 2076-2082
  • 23 Roncucci L, Fante R, Losi L. Survival for colon and rectal cancer in a population-based cancer registry.  Eur J Cancer . 1996;  32A 295-302
  • 24 Crucitti F, Sofo L, Doglietto G. Prognostic factors in colorectal cancer: current status and new trends.  J Surg Oncol . 1991;  2 76-82
  • 25 Michelassi F, Ayala J, Balestracci T. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.  Ann Surg . 1991;  214 11-18
  • 26 Michelassi F, Block G E, Vannucci L. A 5- to 21-year follow-up and analysis of 250 patients with rectal adenocarcinoma.  Ann Surg . 1988;  208 379-387
  • 27 Carlon C, Fabris G, Arslan-Pagnini C. Prognostic correlations of operable carcinoma of the rectum.  Dis Colon Rectum . 1985;  28 47-50
  • 28 Green J, Timmcke A, Mitchell W. Mucinous carcinoma-Just another colon cancer?.  Dis Colon Rectum . 1993;  36 49-54
  • 29 Hermanek P, Guggenmoos-Holzmann I, Gall F P. Prognostic factors in rectal carcinoma. A contribution to the further development of tumor classification.  Dis Colon Rectum . 1989;  32 593-599
  • 30 Jass J, Atkin W, Cuzick J. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases.  Histopathology . 1986;  10 437-459
  • 31 Jass J, Love S, Northover J. A new prognostic classification of rectal cancer.  Lancet . 1987;  I 1303-1306
  • 32 Robey-Cafferty S S, el-Naggar A K, Grignon D J. Histologic parameters and DNA ploidy as predictors of survival in stage B adenocarcinoma of colon and rectum.  Mod Pathol . 1990;  193 261-266
  • 33 Spratt J, Spjut H. Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma.  Cancer . 1967;  20 1976-1985
  • 34 Umpleby H C, Williamson R C. Carcinoma of the large bowel in the first four decades.  Br J Surg . 1984;  71 272-277
  • 35 Compton C C, Fielding L P, Burgart L J. Prognostic factors in colorectal cancer: College of American Pathologists Consensus Statement 1999.  Arch Pathol Lab Med . 2000;  124 979-994
  • 36 Jesserun J, Romero-Guadarrama M, Manivel J C. Medullary adenocarcinoma of the colon: clinicopathologic study of 11 cases.  Hum Pathol . 1999;  30 843-848
  • 37 Rüschoff J, Dietmaier W, Lüttges J. Poorly differentiated colonic adenocarcinoma, medullary type. Clinical, phenotypic and molecular characteristics.  Am J Pathol . 1997;  150 1815-1825
  • 38 Jass J, Smyrk T C, Stewart S M. Pathology of hereditary nonpolyposis colon cancer.  Anticancer Res . 1994;  14 1631-1634
  • 39 Kim H, Jen J, Vogelstein B. Clinical and pathological characteristics of sporadic colon carcinomas with DNA replication errors in microsatellite sequences.  Am J Pathol . 1994;  145 148-156
  • 40 Lynch H T, Smyrk T C, Watson P. Genetics, natural history, tumor spectrum, and pathology of hereditary non-polyposis colon cancer: an updated review.  Gastroenterology . 1993;  104 1535-1549
  • 41 Mecklin J P, Sipponen P, Jarvinen H J. Histopathology of colorectal carcinomas and adenomas in cancer family syndrome.  Dis Colon Rectum . 1986;  29 849-853
  • 42 Minsky B, Mies C, Rich T. Colloid carcinoma of the colon and rectum.  Cancer . 1987;  60 3103-3112
  • 43 Secco G, Fardelli R, Campora E. Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum.  Oncology . 1994;  51 30-34
  • 44 Symonds D, Vickery A. Mucinous carcinoma of the colon and rectum.  Cancer . 1976;  37 1891-1900
  • 45 Heys S, Sherif A, Bagley J. Prognostic factors and survival of patients aged less than 45 years with colorectal cancer.  Br J Surg . 1994;  81 685-688
  • 46 Harrison J, Dean P, El-Zeky F. From Dukes through Jass: pathological prognostic indicators in rectal cancer.  Hum Pathol . 1994;  25 498-505
  • 47 Sasaki O, Atkin W S, Jass J R. Mucinous carcinoma of the rectum.  Histopathology . 1987;  11 259-272
  • 48 Shepherd N, Saraga E, Love S. Prognostic factors in colonic cancer.  Histopathology . 1989;  14 613-620
  • 49 Mulcahy H E, Skelly M M, Husain A. Long-term outcome following curative surgery for malignant large bowel obstruction.  Br J Surg . 1996;  83 46-50
  • 50 Halvorsen E, Seim E. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer.  J Clin Pathol . 1989;  42 162-166
  • 51 Öfner D, Riedmann B, Maier H. Standardized staining and analysis of argyrophilic nucleolar organizer region associated proteins (AgNORs) in radically resected colorectal adenocarcinoma-correlation with tumour stage and long-term survival.  J Pathol . 1995;  75 441-448
  • 52 Staren E D, Gould V E, Warren W H. Neuroendocrine carcinomas of the colon and rectum: a clinicopathologic correlation.  Surgery . 1988;  104 1080-1089
  • 53 DeBruine A, Wiggers T, Beek C. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance.  Int J Cancer . 1993;  54 765-771
  • 54 Gaffey M, Mills S, Lack E. Neuroendocrine carcinoma of the colon and rectum. A clinicopathologic, ultrastructural, and immunohistochemical study of 24 cases.  Am J Surg Path . 1990;  14 1010-1023
  • 55 Goldstein N S, Hart J. Histologic features associated with lymph node metastasis in stage TI and superficial T2 rectal adenocarcinomas in abdominoperineal resections. Identifying a subset of patients for whom treatment with adjuvant therapy or completion abdominoperineal resection should be considered after local excision.  Am J Clin Pathol . 1999;  111 51-58
  • 56 Dukes C E. The classification of cancer of the rectum.  J Pathol Bacteriol . 1932;  35 323-332
  • 57 Grinnell R S. The grading and prognosis of carcinoma of the colon and rectum.  Ann Surg . 1939;  109 500-533
  • 58 Jass J R, Morson B C. Reporting colorectal cancer.  J Clin Pathol . 1987;  40 1016-1023
  • 59 Saclarides T J, Bhattacharyya A K, Britton-Kuzel C. Predicting lymph node metastases in rectal cancer.  Dis Colon Rectum . 1994;  37 52-57
  • 60 Wehrmann M, Greschniok A, Offenhaeuser S. Staging, grading, and related histopathological techniques in local therapy of rectal tumors.  End Surg . 1994;  2 237-240
  • 61 Dukes C E, Bussey H J. The spread of rectal cancer and its effect on prognosis.  Br J Cancer . 1958;  12 309-320
  • 62 Thomas G DH, Dixon M F, Smeeton N C. Observer variation in the histologic grading of rectal carcinoma.  J Clin Pathol . 1983;  36 385-391
  • 63 Huddy S P, Husband E M, Cook M G. Lymph node metastasis in early rectal cancer.  Br J Surg . 1993;  80 1457-1458
  • 64 Gagliardi G, Stepniewska K A, Hershman M J. New grade-related prognostic variable for rectal cancer.  Br J Surg . 1995;  82 599-602
  • 65 Fisher E R, Robinsky B, Sass R. Relative prognostic value of the Dukes and Jass systems in rectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Projects (protocol R-01).  Dis Colon Rectum . 1989;  32 944-949
  • 66 Blenkinsopp W K, Stewart-Brown S, Blesovsky L. Histopathology reporting in large bowel cancer.  J Clin Pathol . 1981;  34 509-513
  • 67 Chapuis P H, Dent O F, Fisher R. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer.  Br J Surg . 1985;  72 698-702
  • 68 D'Eredita G, Serio G, Neri V. A survival regression analysis of prognostic factors in colorectal cancer.  Aust NZ J Surg . 1996;  66 445-451
  • 69 Griffin M, Bergstralh E, Coffey R. Predictors of survival after curative resection of carcinoma of the colon and rectum.  Cancer . 1987;  60 2318-2324
  • 70 Deans G, Heatley M, Anderson N. Jass' classification revisited.  J Am Coll Surg . 1994;  179 11-17
  • 71 Freedman L, Macaskill P, Smith A. Multivariate analysis of prognostic factors for operable rectal cancer.  Lancet . 1984;  II 733-736
  • 72 Böttger T C, Potratz D, Stöckle M. Prognostic value of DNA analysis in colorectal carcinoma.  Cancer . 1993;  72 3579-3587
  • 73 Fisher E, Sass R, Palekar A. Dukes' classification revisited. Findings from the National Surgical Adjuvant Breast and Bowel Projects.  Cancer . 1989;  64 2354-2360
  • 74 Jessup J M, Lavin P T, Andrews C W. Sucrase-isomaltase is an independent prognostic marker for colorectal carcinoma.  Dis Colon Rectum . 1995;  38 1257-1264
  • 75 Jessup J, McGinnis L, Steele G. The National Cancer Data Base Report on Colon Cancer.  Cancer . 1996;  78 918-926
  • 76 Rüschoff J, Bittinger A, Neumann K. Prognostic significance of nucleolar organizing regions (NORs) in carcinomas of the sigmoid colon and rectum.  Path Res Pract . 1990;  186 85-91
  • 77 Scott N A, Wieand H S, Moertel C G. Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern.  Arch Surg . 1987;  122 1375-1379
  • 78 Wiggers T, Arends J, Volovics A. Regression analysis of prognostic factors in colorectal cancer after curative resections.  Dis Colon Rectum . 1988;  31 33-41
  • 79 Gospodarowicz M K, Henson D E, Hutter RVP (eds), et al. Prognostic Factors in Cancer. 2nd ed. New York: Wiley-Liss 2001
  • 80 Fleming I D, Cooper J S, Henson D E. AJCC Manual for Staging of Cancer.  5th ed. Philadelphia: Lippincott Raven 1997
  • 81 Wittekind C, Henson D E, Hutter R VP, Sobin L H, eds. TNM Supplement. A Commentary on Uniform Use. 2nd ed. New York: Wiley-Liss 2001
  • 82 Scott K WM, Grace R H. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance.  Br J Surg . 1989;  76 1165-1167
  • 83 Tepper J E, O'Connell M J, Niedzwiecki D. Impact of number of nodes retrieved on outcome in patients with rectal cancer.  J Clin Oncol . 2001;  19 157-163
  • 84 Greene F L, Balch C M, Fleming I D, et a l, eds. AJCC Manual for Staging of Cancer. 6th ed. New York: Springer Verlag In press 2002
  • 85 Goldstein N S, Turner J R. Pericolonic tumor deposits in patients with T3N+M0 colon adenocarcinomas. Markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification.  Cancer . 2000;  88 2228-2238
  • 86 Wittekind C, Compton C C, Sobin L H. Residual tumour classification revisited. In press.  Cancer 2001.
  • 87 Willett C G, Tepper J E, Wood W C. Patterns of failure following local excision and post-operative radiation therapy for invasive rectal adenocarcinoma.  J Clin Oncol . 1989;  7 1003-1008
  • 88 Quirke P, Scott N. The pathologist's role in the assessment of local recurrence in rectal carcinoma.  Surg Oncol Clin N Amer . 1992;  3 1-17
  • 89 Quirke P, Durdy P, Dixon M F, Williams N S. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection.  Lancet . 1986;  II 996-999
  • 90 Adam I J, Mohamdee M O, Martin I G. Role of the circumferential margin involvement in the local recurrence of rectal cancer.  Lancet . 1994;  344 707-711
  • 91 Chan K, Boey J, Wong S. A method of reporting radial invasion and surgical clearance of rectal carcinoma.  Histopathology . 1985;  9 1319-1327
  • 92 Nagtegaal I D, van der Worp E, van de Velde J C. Macroscopic evaluation of rectal cancer resection specimens: clinical significance of the pathologist in quality control. In press.  J Clin Oncol . 2002; 
  • 93 Knudsen J B, Nilsson T, Sprechler M. Venous and nerve invasion as prognostic factors in postoperative survival of patients with resectable cancer of the rectum.  Dis Colon Rectum . 1983;  26 613-617
  • 94 Takebayashi Y, Akiyama S, Yamada K. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma.  Cancer . 1996;  78 226-231
  • 95 Lee Y. Local and regional recurrence of carcinoma of the colon and rectum: I. Tumour-host factors and adjuvant therapy.  Surg Oncol . 1995;  4 283-293
  • 96 Takahashi Y, Tucker S, Kitadai Y. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer.  Arch Surg . 1997;  132 541-546
  • 97 Minsky B, Mies C, Recht A. Resectable adenocarcinoma of the rectosigmoid and rectum. II. The influence of blood vessel invasion.  Cancer . 1988;  61 1417-1424
  • 98 Minsky B, Mies C, Rich T. Lymphatic vessel invasion is an independent prognostic factor for survival in colorectal cancer.  Int J Radiat Oncol Biol Phys . 1989;  17 311-318
  • 99 Cranley J P, Petras R E, Carey W D. When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma?.  Gastroenterology . 1986;  91 419-427
  • 100 Cooper H S. Surgical pathology of endoscopically removed malignant polyps of the colon and rectum.  Am J Surg Path . 1983;  7 613-623
  • 101 Cooper H S. The role of the pathologist in the management of patients with endoscopically removed malignant colorectal polyps.  Pathol Annual . 1988;  23 25-43
  • 102 Cooper H S, Deppisch L M, Kahn E I. Pathology of the malignant colorectal polyp.  Hum Pathol . 1998;  29 15-26
  • 103 Cunningham K N, Mills L R, Schuman B M. Long-term prognosis of well-differentiated adenocarcinoma in endoscopically removed colorectal adenomas.  Dig Dis Sci . 1994;  39 2034-2037
  • 104 Haggitt R C, Glotzbach R E, Soffer E E. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy.  Gastroenterology . 1985;  89 328-336
  • 105 Lipper S, Kahn L B, Ackerman L V. The significance of microscopic invasive cancer in endoscopically removed polyps of the large bowel. A clinicopathologic study of 51 cases.  Cancer . 1983;  52 1691-1699
  • 106 Kyzer S, Begin L R, Gordan P H. The care of patients with colorectal polyps that contain invasive adenocarcinoma.  Cancer . 1992;  70 2044-2050
  • 107 Muller S, Chesner I M, Egan M J. Significance of venous and lymphatic invasion in malignant polyps of the colon and rectum.  Gut . 1989;  30 1385-1391
  • 108 Volk E E, Goldblum J R, Petras R E. Management and outcome of patients with invasive carcinoma arising in colorectal polyps.  Gastroenterology . 1995;  109 1801-1807
  • 109 Shepherd N, Baxter K, Love S. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation.  Gastroenterology . 1997;  112 1096-1102
  • 110 Hase K, Shatney C, Johnson D. Prognostic value of tumor ``budding'' in patients with colorectal cancer.  Dis Colon Rectum . 1993;  36 627-635
  • 111 Thynne G S, Weiland L H, Moertel C G. Correlation of histopathologic characteristics of primary tumor and uninvolved regional lymph nodes in Dukes' C colonic carcinoma with prognosis.  Mayo Clin Proc . 1980;  55 243-245
  • 112 Volk E E, Goldblum J R, Petras R E. Management and outcome of patients with invasive carcinoma arising in colorectal polyps.  Gastroenterology . 1995;  109 1801-1807
  • 113 Shirouzu K, Isomoto H, Kakegawa T. Prognostic evaluation of perineural invasion in rectal cancer.  Am J Surg . 1993;  165 233-237
  • 114 Pihl E, Malahy M A, Khankhanian N. Immunomorphological features of prognostic significance in Dukes' class B colorectal carcinoma.  Cancer Res . 1977;  37 4145-4149
  • 115 Svennevig J L, Lunde O C, Holter J. Lymphoid infiltration and prognosis in colorectal carcinoma.  Br J Cancer . 1984;  49 375-377
  • 116 Zhou X G, Yu B M, Shen Y X. Surgical treatment and late results in 1226 cases of colorectal cancer.  Dis Colon Rectum . 1983;  26 250-256
  • 117 Jass J R, Do K A, Simms L A. Morphology of sporadic colorectal cancer with DNA replication errors.  Gut . 1988;  42 673-679